Teymourian Hazhir, Parrilla Marc, Sempionatto Juliane R, Montiel Noelia Felipe, Barfidokht Abbas, Van Echelpoel Robin, De Wael Karolien, Wang Joseph
Department of Nanoengineering, University of California San Diego, La Jolla, California 92093, United States.
AXES Research Group, Bioscience Engineering Department, Groenenborgerlaan 171, 2020 Antwerp, Belgium.
ACS Sens. 2020 Sep 25;5(9):2679-2700. doi: 10.1021/acssensors.0c01318. Epub 2020 Aug 21.
Wearable electrochemical sensors capable of noninvasive monitoring of chemical markers represent a rapidly emerging digital-health technology. Recent advances toward wearable continuous glucose monitoring (CGM) systems have ignited tremendous interest in expanding such sensor technology to other important fields. This article reviews for the first time wearable electrochemical sensors for monitoring therapeutic drugs and drugs of abuse. This rapidly emerging class of drug-sensing wearable devices addresses the growing demand for personalized medicine, toward improved therapeutic outcomes while minimizing the side effects of drugs and the related medical expenses. Continuous, noninvasive monitoring of therapeutic drugs within bodily fluids empowers clinicians and patients to correlate the pharmacokinetic properties with optimal outcomes by realizing patient-specific dose regulation and tracking dynamic changes in pharmacokinetics behavior while assuring the medication adherence of patients. Furthermore, wearable electrochemical drug monitoring devices can also serve as powerful screening tools in the hands of law enforcement agents to combat drug trafficking and support on-site forensic investigations. The review covers various wearable form factors developed for noninvasive monitoring of therapeutic drugs in different body fluids and toward on-site screening of drugs of abuse. The future prospects of such wearable drug monitoring devices are presented with the ultimate goals of introducing accurate real-time drug monitoring protocols and autonomous closed-loop platforms toward precise dose regulation and optimal therapeutic outcomes. Finally, current unmet challenges and existing gaps are discussed for motivating future technological innovations regarding personalized therapy. The current pace of developments and the tremendous market opportunities for such wearable drug monitoring platforms are expected to drive intense future research and commercialization efforts.
能够无创监测化学标志物的可穿戴电化学传感器是一种迅速兴起的数字健康技术。可穿戴连续血糖监测(CGM)系统的最新进展引发了人们对将这种传感器技术扩展到其他重要领域的极大兴趣。本文首次综述了用于监测治疗药物和滥用药物的可穿戴电化学传感器。这类迅速兴起的可穿戴药物传感设备满足了对个性化医疗日益增长的需求,有助于改善治疗效果,同时将药物副作用和相关医疗费用降至最低。通过实现针对患者的剂量调节并跟踪药代动力学行为的动态变化,同时确保患者的用药依从性,对体液中的治疗药物进行连续、无创监测,可使临床医生和患者将药代动力学特性与最佳治疗效果相关联。此外,可穿戴电化学药物监测设备还可成为执法人员手中打击毒品贩运和支持现场法医调查的有力筛查工具。该综述涵盖了为无创监测不同体液中的治疗药物以及现场筛查滥用药物而开发的各种可穿戴形式。文中介绍了此类可穿戴药物监测设备的未来前景,其最终目标是引入准确的实时药物监测方案和自主闭环平台,以实现精确的剂量调节和最佳治疗效果。最后,讨论了当前尚未解决的挑战和现存差距,以激发未来关于个性化治疗的技术创新。预计此类可穿戴药物监测平台当前的发展速度和巨大的市场机遇将推动未来激烈的研究和商业化努力。